| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/B914943K |
| P8608 | Fatcat ID | release_pd5bxivukbe6vp6mbvy4yafixq |
| P698 | PubMed publication ID | 21060941 |
| P5875 | ResearchGate publication ID | 47718871 |
| P50 | author | Bruno De Geest | Q55231999 |
| Bart Lambrecht | Q18402373 | ||
| Yvette van Kooyk | Q29914012 | ||
| P2093 | author name string | Chris Vervaet | |
| Jean Paul Remon | |||
| Johan Grooten | |||
| Stefaan De Koker | |||
| Monique A Willart | |||
| P2860 | cites work | Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. | Q51615861 |
| Novel Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes. | Q52803764 | ||
| Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. | Q53000998 | ||
| Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites | Q55966433 | ||
| Nanoengineering of Inorganic and Hybrid Hollow Spheres by Colloidal Templating | Q56603709 | ||
| A Protective Vaccine Delivery System for In Vivo T Cell Stimulation Using Nanoengineered Polymer Hydrogel Capsules | Q56769270 | ||
| Binding, Internalization, and Antigen Presentation of Vaccine-Loaded Nanoengineered Capsules in Blood | Q56769307 | ||
| A single step process for the synthesis of antigen laden thermosensitive microparticles | Q57366863 | ||
| Mesoporous Silica Particles as Templates for Preparing Enzyme-Loaded Biocompatible Microcapsules | Q57645451 | ||
| NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells | Q58007061 | ||
| Antigen presentation by dendritic cells in vivo | Q58757885 | ||
| Toll-dependent selection of microbial antigens for presentation by dendritic cells | Q59063722 | ||
| Innate immune recognition: mechanisms and pathways | Q28138782 | ||
| Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial | Q28236008 | ||
| ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells | Q28506676 | ||
| Phagosomes are competent organelles for antigen cross-presentation | Q28591811 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Differential antigen processing by dendritic cell subsets in vivo | Q29615177 | ||
| Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants | Q29615635 | ||
| Recognition of microorganisms and activation of the immune response | Q29617903 | ||
| Biodegradable microcapsules designed via 'click' chemistry | Q45413284 | ||
| Nanoparticles target distinct dendritic cell populations according to their size | Q45732404 | ||
| Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice | Q45876568 | ||
| Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres | Q46322113 | ||
| Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy | Q46530740 | ||
| Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation | Q46674193 | ||
| Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency | Q46856102 | ||
| Disulfide cross-linked polymer capsules: en route to biodeconstructible systems | Q46883695 | ||
| Effect of protein molecular weight on release from micron-sized PLGA microspheres | Q47201582 | ||
| Layer-by-layer coating of degradable microgels for pulsed drug delivery. | Q49076786 | ||
| Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross-presentation of encapsulated antigens | Q49123460 | ||
| Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes | Q50335815 | ||
| Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. | Q51253137 | ||
| Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). | Q51323708 | ||
| Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells. | Q51357882 | ||
| Directed cell migration via chemoattractants released from degradable microspheres. | Q51528715 | ||
| Protein encapsulation via porous CaCO3 microparticles templating | Q33206684 | ||
| Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen | Q33215079 | ||
| Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. | Q33282108 | ||
| Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation | Q33282281 | ||
| Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation | Q33767232 | ||
| CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 | ||
| New advances in microsphere-based single-dose vaccines | Q33933148 | ||
| Protein release from alginate matrices | Q33933226 | ||
| Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines | Q33933255 | ||
| Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates | Q34162875 | ||
| In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles | Q34234901 | ||
| Sensing pathogens and tuning immune responses | Q34308011 | ||
| Chitosan as a novel nasal delivery system for vaccines | Q34343257 | ||
| Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development | Q34446194 | ||
| Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors | Q34588908 | ||
| Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. | Q34623431 | ||
| Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells | Q34764301 | ||
| Taking toll: lipid A mimetics as adjuvants and immunomodulators | Q34960326 | ||
| Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy | Q34968934 | ||
| A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels | Q34981649 | ||
| Microparticles as vaccine adjuvants and delivery systems | Q35192199 | ||
| Recent advances in the discovery and delivery of vaccine adjuvants | Q35209997 | ||
| Toll-like receptors and acquired immunity | Q35642955 | ||
| Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens | Q35826361 | ||
| Modulating vaccine responses with dendritic cells and Toll-like receptors | Q35826412 | ||
| Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents | Q35842681 | ||
| Formulation aspects of biodegradable polymeric microspheres for antigen delivery | Q35961150 | ||
| Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens | Q35961159 | ||
| Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity | Q36088964 | ||
| Targeting the innate immune response with improved vaccine adjuvants | Q36090194 | ||
| Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance | Q36376611 | ||
| CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity | Q36380885 | ||
| Translating innate immunity into immunological memory: implications for vaccine development | Q36404657 | ||
| Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines | Q36447615 | ||
| Expanding the effector CD4 T-cell repertoire: the Th17 lineage. | Q36449975 | ||
| Microparticle-based technologies for vaccines | Q36602257 | ||
| Targeting dendritic cells with biomaterials: developing the next generation of vaccines | Q36627404 | ||
| Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines | Q36678106 | ||
| Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens | Q36689895 | ||
| New hepatitis B vaccine formulated with an improved adjuvant system | Q36780117 | ||
| Next generation, sequentially assembled ultrathin films: beyond electrostatics | Q36807527 | ||
| The perfect mix: recent progress in adjuvant research | Q36844715 | ||
| Toll-like receptor ligands energize peptide vaccines through multiple paths | Q36931433 | ||
| Recent advances in antigen processing and presentation | Q36945533 | ||
| Vaccine immunopotentiators of the future | Q36959938 | ||
| Cationic liposomes as vaccine adjuvants | Q36968290 | ||
| Bridging the knowledge gaps in vaccine design | Q37027137 | ||
| Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome | Q37070610 | ||
| Endocytosis mechanisms and the cell biology of antigen presentation | Q37076774 | ||
| The cell biology of cross-presentation and the role of dendritic cell subsets | Q37082455 | ||
| Monocyte-derived dendritic cells in innate and adaptive immunity | Q37117563 | ||
| Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells | Q37139993 | ||
| The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells | Q37327058 | ||
| Mechanism of action of clinically approved adjuvants | Q37402088 | ||
| A functional dichotomy in CD4+ T lymphocytes | Q39473413 | ||
| Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. | Q39995184 | ||
| Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity | Q40062912 | ||
| Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. | Q40077642 | ||
| Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles | Q40327793 | ||
| Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells | Q40351226 | ||
| Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery | Q40713744 | ||
| Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide) | Q42806631 | ||
| A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules | Q43466825 | ||
| Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines | Q43631849 | ||
| Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity | Q43883594 | ||
| Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy | Q44032648 | ||
| A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers | Q44180226 | ||
| Pulsed in vitro release and in vivo behavior of exploding microcapsules | Q44312979 | ||
| The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles | Q44467598 | ||
| Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity | Q44887736 | ||
| Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy | Q44942720 | ||
| TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses | Q44997831 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 320-339 | |
| P577 | publication date | 2010-11-09 | |
| P1433 | published in | Chemical Society Reviews | Q2962268 |
| P1476 | title | Designing polymeric particles for antigen delivery | |
| P478 | volume | 40 |
| Q49131201 | A Modular Approach To Study Protein Adsorption on Surface Modified Hydroxyapatite |
| Q58692952 | A Three Component Synthetic Vaccine Containing a β-Mannan T-Cell Peptide Epitope and a β-Glucan Dendritic Cell Ligand |
| Q40694699 | Acid-Labile Thermoresponsive Copolymers That Combine Fast pH-Triggered Hydrolysis and High Stability under Neutral Conditions |
| Q89983778 | Advanced biomaterials for cancer immunotherapy |
| Q36501913 | An automated two-phase system for hydrogel microbead production. |
| Q48684399 | Capturing "Extraordinary" Soft-Assembled Charge-Like Polypeptides as a Strategy for Nanocarrier Design |
| Q38566314 | Chitosan-based mucosal adjuvants: Sunrise on the ocean |
| Q42259049 | Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis |
| Q41654079 | Core/shell protein-reactive nanogels via a combination of RAFT polymerization and vinyl sulfone postmodification |
| Q38912004 | Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy? |
| Q40101820 | Direct Loading of iTEP-Delivered CTL Epitope onto MHC Class I Complexes on the Dendritic Cell Surface. |
| Q57376730 | Double emulsion template suspension polymerisation: towards the synthesis of polyelectrolyte core porous hydrophobic shell particles for environmental applications |
| Q57364789 | Dual pH- and temperature-responsive RAFT-based block co-polymer micelles and polymer–protein conjugates with transient solubility |
| Q49090708 | Engineering Polymer Hydrogel Nanoparticles for Lymph Node-Targeted Delivery |
| Q51005289 | Mechanically tunable, self-adjuvanting nanoengineered polypeptide particles. |
| Q42549655 | Microcapsules functionalized with neuraminidase can enter vascular endothelial cells in vitro |
| Q38073752 | Modern subunit vaccines: development, components, and research opportunities |
| Q35788471 | Modulating adaptive immune responses to peptide self-assemblies |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q42235032 | Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms |
| Q38586079 | Nucleic acid vaccination strategies against infectious diseases. |
| Q58385253 | Particulate transepithelial drug carriers: barriers and functional polymers |
| Q37979152 | Polymeric multilayer capsules for drug delivery |
| Q26752054 | Recent advances of biomaterials in biotherapy |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q36083687 | Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope |
| Q36998403 | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. |
| Q46930554 | Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages |
| Q49030612 | Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function |
| Q57644957 | Targeting Dendritic Cells: The Role of Specific Receptors in the Internalization of Polymer Capsules |
| Q34532116 | Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen |
| Q37484860 | Thymus transcriptome reveals novel pathways in response to avian pathogenic Escherichia coli infection |
| Q36512540 | Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. |
| Q95322966 | Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy |
Search more.